Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2da41c5eb6f6edee21cb549094e8dd6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b3cc8121bf22d29e867c10ca5baa17f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
filingDate |
2009-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d61288e33f507f6ca225b5b666e12036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baae3b303a184ed412ceef1408e6abb5 |
publicationDate |
2009-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2009298774-A1 |
titleOfInvention |
Bifunctional Molecules for Inhibiting HIV Entry |
abstract |
Disclosed herein are bifunctional molecules which inhibit HIV entry into the target cell. Also disclosed are novel anti-HIV therapeutics for treatment of patients infected by HIV, including non-B and multi-drug resistant strains. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200002923-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11680086-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2741123-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018191858-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102389792-B1 |
priorityDate |
2008-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |